Pharmafile Logo
Pharmafocus logo
Advanced Search
Germany image

Germany focus: strength with control

February 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMNOG, EFPIA, Germany, IQWIG, NHS, NICE

Germany is the biggest pharmaceutical market in Europe and one of the biggest in the world, but new systems and …

Feature
graham_hetherington_shire

Shire chief financial officer steps down

February 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, hetherington

Shire’s chief financial officer (CFO) Graham Hetherington has notified the company of his decision to step down. Flemming Ornskov, Shire …

Appointment
gsk_through_window

Pharma’s reputation ‘getting worse’

February 17, 2014
Medical Communications, Sales and Marketing GSK, Gilead, Pfizer, ViiV, patientview, pharma, reputation

The pharma industry’s reputation is getting worse – at least, in the eyes of 800 patient groups – according to …

News

‘Wraptac’ print your own label for the Clinical Trials Industry

February 14, 2014

News
Press release

‘More than 2,000’ US lawsuits for Boehringer

February 14, 2014
Sales and Marketing Boehringer, Pradaxa, Xarelto, blood thinner, warfarin

Boehringer Ingelheim is facing more than 2,000 lawsuits in the US over allegations that its stroke prevention pill Pradaxa has …

News
Stuart rose image

Former M&S chief executive to headhunt for NHS

February 14, 2014
Medical Communications, Sales and Marketing Dalton, Hunt, NHS, stuart rose, superheads

Health secretary Jeremy Hunt has appointed the man accredited with turning around the fortunes of Marks and Spencer to advise …

News
Shire HQ

Shire’s Vyvanse could bring in new revenue

February 14, 2014
Medical Communications, Research and Development, Sales and Marketing ADHD, Shire, Vyvanse, binge eating, generics

News
Pfizer image

Pfizer faces Australia action

February 14, 2014
Medical Communications, Sales and Marketing Australia, Lipitor, Pfizer, accc

Pfizer has a legal battle on its hands in Australia, where the country’s consumer watchdog has begun proceedings in the …

News
capture

Emperra appoints new chief executive

February 14, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing e-health, emperra, krey

Healthcare development firm Emperra E-Health Technologies has hired Dr Christian Krey as managing director and chief executive. Krey was previously …

Appointment

Doctors highlight NHS data concerns

February 13, 2014
Medical Communications, Sales and Marketing NHS, RGCP, UK, care data, doctors

Senior doctors have voiced their worries about the public’s lack of preparedness for the government’s planned roll-out of patient data …

News
Janssen image

FDA extends licence for Janssen’s Imbruvica

February 13, 2014
Sales and Marketing FDA, Janssen, durect, imbruvica, leukaemia

Janssen and partner Pharmacyclics have been given an extended FDA approval for their new blood cancer treatment Imbruvica. The US …

News

Aesica hires director from Catalent

February 13, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aesica, Catalent, muir

Contract development and manufacturing organisation (CDMO) Aesica has appointed Ian Muir to the newly-created position of commercial managing director. Muir’s …

Appointment
roche image

Kadcyla launches in UK

February 13, 2014
Sales and Marketing CDF, Cancer, Kadcyla, NHS, Roche, breast

 Roche’s Kadcyla, indicated to treat an aggressive form of breast cancer, has launched today in the UK.Kadcyla (trastuzumab emtansine) which …

News

NHS England savings ‘not used wisely’

February 12, 2014
Sales and Marketing England, NHS, QIPP, Simon Stevens, health select

A group of influential MPs has raised serious concerns over what the £10 billion worth of NHS England savings made …

News
NICE image

NICE: ‘Use more statins’

February 12, 2014
Sales and Marketing NHS, NICE, baker, cvd, statins

NICE has decided more NHS patients ought to be considered at risk of cardiovascular disease (CVD) – and therefore advises …

News
ICR image

ICR: ‘Pharma needs stronger incentives’

February 12, 2014
Research and Development, Sales and Marketing ICR, cancer research, itcc, pharma, r and d

The pharma industry must be given greater monetary help to persuade it to develop drugs which are specifically for children, …

News
Teva image

Teva under investigation for marketing practices

February 12, 2014
Sales and Marketing Azilect, Copaxone, Teva, fines, generics

Teva Pharmaceuticals is under investigation by US authorities for sales and marketing activity around two of its drugs – including …

News

Merck KGaA pushes biosimilars

February 12, 2014
Research and Development, Sales and Marketing Dr Reddy's, Merck KGaA, biosimilars, dr reddys, generics

Merck KGaA is to take big strides into the world of biosimilars, according to the German company’s chairman Karl-Ludwig Kley. …

News

New chief executive for Biotec

February 12, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biotec, UK, withey

Pharma supplies firm Biotec Services International has promoted Dr Fiona Withey to the position of chief executive.



  Withey joined the …

Appointment

RSA confirms three appointments

February 12, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing chin, foster, macdonald, rsa

Life sciences executive search and interim management firm RSA has increased the size of its offering with three new appointments. …

Appointment
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026